206 related articles for article (PubMed ID: 34948449)
41. Drugmakers cling to dual IL-13/IL-4 blockbuster hopes.
Sheridan C
Nat Biotechnol; 2018 Jan; 36(1):3-5. PubMed ID: 29319691
[No Abstract] [Full Text] [Related]
42. IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma.
Nur Husna SM; Md Shukri N; Mohd Ashari NS; Wong KK
PeerJ; 2022; 10():e13444. PubMed ID: 35663523
[TBL] [Abstract][Full Text] [Related]
43. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
44. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
[TBL] [Abstract][Full Text] [Related]
45. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis.
Werfel T; Morita A; Grewe M; Renz H; Wahn U; Krutmann J; Kapp A
J Invest Dermatol; 1996 Dec; 107(6):871-6. PubMed ID: 8941677
[TBL] [Abstract][Full Text] [Related]
46. Topical skin treatment with Fab fragments of an allergen-specific IgG1 monoclonal antibody suppresses allergen-induced atopic dermatitis-like skin lesions in mice.
Sae-Wong C; Mizutani N; Kangsanant S; Yoshino S
Eur J Pharmacol; 2016 May; 779():131-7. PubMed ID: 26970183
[TBL] [Abstract][Full Text] [Related]
47. Polyclonal and allergen-induced cytokine responses in children with elevated immunoglobulin E but no atopic disease.
Smart JM; Tang ML; Kemp AS
Clin Exp Allergy; 2002 Nov; 32(11):1552-7. PubMed ID: 12569974
[TBL] [Abstract][Full Text] [Related]
48. [The investigation of asthmatic children by multiple factor analysis. II. The influence of 17 allergic factors on atopic dermatitis and allergic rhinitis in asthmatic children].
Koya N; Suzuki S; Hara M; Tateno A; Saito S; Nakazato E
Arerugi; 1989 Nov; 38(11):1255-67. PubMed ID: 2627160
[TBL] [Abstract][Full Text] [Related]
49. The role of interleukin-1β in the immune response to contact allergens.
Yeung K; Mraz V; Geisler C; Skov L; Bonefeld CM
Contact Dermatitis; 2021 Oct; 85(4):387-397. PubMed ID: 34324721
[TBL] [Abstract][Full Text] [Related]
50. Mite antigen-induced IL-4 and IL-13 production by basophils derived from atopic asthma patients.
Shimizu Y; Shichijo M; Hiramatsu K; Takeuchi M; Nagai H; Takagi K
Clin Exp Allergy; 1998 Apr; 28(4):497-503. PubMed ID: 9641578
[TBL] [Abstract][Full Text] [Related]
51. Immunological response to Parthenium hysterophorus in Indian Patients with Parthenium sensitive atopic dermatitis.
Kumar S; Khandpu S; Rao DN; Wahaab S; Khanna N
Immunol Invest; 2012; 41(1):75-86. PubMed ID: 22091625
[TBL] [Abstract][Full Text] [Related]
52. STAT6 Regulates the Development of Eosinophilic versus Neutrophilic Asthma in Response to Alternaria alternata.
Valladao AC; Frevert CW; Koch LK; Campbell DJ; Ziegler SF
J Immunol; 2016 Dec; 197(12):4541-4551. PubMed ID: 27815425
[TBL] [Abstract][Full Text] [Related]
53. Sensitization to Molecular Components in 104 Atopic Dermatitis Patients in Relation to Subgroups of Patients Suffering from Bronchial Asthma and Allergic Rhinitis.
Vaňková R; Čelakovská J; Bukač J; Krčmová I; Krejsek J; Andrýs C
Acta Medica (Hradec Kralove); 2020; 63(4):164-175. PubMed ID: 33355077
[TBL] [Abstract][Full Text] [Related]
54. Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis.
Kanda N; Watanabe S
J Invest Dermatol; 2002 Sep; 119(3):590-9. PubMed ID: 12230500
[TBL] [Abstract][Full Text] [Related]
55. Role of Superantigens in Allergic Inflammation: Their Relationship to Allergic Rhinitis, Chronic Rhinosinusitis, Asthma, and Atopic Dermatitis.
Muluk NB; Altın F; Cingi C
Am J Rhinol Allergy; 2018 Nov; 32(6):502-517. PubMed ID: 30253652
[TBL] [Abstract][Full Text] [Related]
56. The Transcription Factor p63 Is a Direct Effector of IL-4- and IL-13-Mediated Repression of Keratinocyte Differentiation.
Brauweiler AM; Leung DYM; Goleva E
J Invest Dermatol; 2021 Apr; 141(4):770-778. PubMed ID: 33038352
[TBL] [Abstract][Full Text] [Related]
57. Analysis of changes in expression of IL-4/IL-13/STAT6 pathway and correlation with the selected clinical parameters in patients with atopic asthma.
Antczak A; Domańska-Senderowska D; Górski P; Pastuszak-Lewandoska D; Nielepkowicz-Goździńska A; Szewczyk K; Kurmanowska Z; Kiszałkiewicz J; Brzeziańska-Lasota E
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):195-204. PubMed ID: 26781462
[TBL] [Abstract][Full Text] [Related]
58. CCL23 expression is induced by IL-4 in a STAT6-dependent fashion.
Novak H; Müller A; Harrer N; Günther C; Carballido JM; Woisetschläger M
J Immunol; 2007 Apr; 178(7):4335-41. PubMed ID: 17371990
[TBL] [Abstract][Full Text] [Related]
59. The use of biologics for immune modulation in allergic disease.
van de Veen W; Akdis M
J Clin Invest; 2019 Mar; 129(4):1452-1462. PubMed ID: 30882368
[TBL] [Abstract][Full Text] [Related]
60. Type-2 inflammatory mediators as targets for precision medicine in children.
Castagnoli R; Licari A; Manti S; Chiappini E; Marseglia GL
Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():17-19. PubMed ID: 33236434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
